Alnylam Pharmaceuticals (A1LN34.SA) Q4 2014 Earnings

5NovConfirmed
Q1 2014
Q2 2014
Q3 2014
Q4 2014
-1.6
-1.36
-1.11
-0.86

Details

Expected EPS
-1.601024
Actual EPS
-1.4509279999999998
Surprise EPS
0.15
Surprise Percent
+9.38%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.4509279999999998 per share for Q4 2014.

0 Comments

Share your thoughts